Cumberland Pharmaceuticals Inc. (CPIX) Operating Margin
- Operating margin · 12 months: Value -7.62%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -7.62% | Operating income / revenue. Period ending 2026-06-30. $-3.04M ÷ $39.90M × 100 ≈ -7.62% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -3.04M USD | Operating Income (Loss) |
| Revenue | 39.90M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 5.58M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-3.04M | $39.90M | (m) | $5.58M | (m) | -7.62% |
| 2026-03-31 | $-7.21M | $41.94M | $7.18M | $5.73M | (m) | -17.20% |
| 2025-12-31 | $-2.79M | $44.52M | $6.67M | $5.57M | (m) | -6.27% |
| 2025-09-30 | $-3.26M | $41.28M | $6.40M | $5.31M | (m) | -7.90% |
| 2025-06-30 | $-2.99M | $42.07M | $6.74M | $5.36M | (m) | -7.11% |
| 2025-03-31 | $-3.27M | $41.08M | $6.44M | $4.95M | (m) | -7.96% |
| 2024-12-31 | $-6.43M | $37.87M | $6.59M | $4.82M | (m) | -16.99% |
| 2024-09-30 | $-10.77M | $36.79M | $6.14M | $4.79M | (m) | -29.28% |
| 2024-06-30 | $-10.94M | $37.79M | $6.58M | $5.41M | (m) | -28.96% |
| 2024-03-31 | $-9.89M | $38.83M | $6.39M | $5.49M | (m) | -25.48% |
| 2023-12-31 | $-9.55M | $39.55M | $6.07M | $5.83M | (m) | -24.16% |
| 2023-09-30 | $-5.65M | $37.99M | $7.19M | $5.98M | (m) | -14.88% |
| 2023-06-30 | $-4.08M | $39.32M | $7.65M | $5.76M | (m) | -10.36% |
| 2023-03-31 | $-5.94M | $38.73M | $8.16M | $6.44M | (m) | -15.35% |
| 2022-12-31 | $-5.70M | $40.68M | $9.12M | $6.69M | (m) | -14.02% |
| 2022-09-30 | $-7.78M | $40.27M | $9.79M | $6.90M | (m) | -19.32% |
| 2022-06-30 | $-9.06M | $36.93M | $8.90M | $6.64M | (m) | -24.52% |
| 2022-03-31 | $-8.65M | $35.68M | $8.61M | $6.17M | (m) | -24.23% |
| 2021-12-31 | $-7.68M | $35.05M | $8.81M | $5.68M | (m) | -21.91% |
| 2021-09-30 | $-5.07M | $36.33M | $7.75M | $5.47M | (m) | -13.96% |
| 2021-06-30 | $-4.71M | $37.50M | $8.57M | $5.25M | (m) | -12.57% |
| 2021-03-31 | $-4.86M | $38.05M | $9.44M | $5.31M | (m) | -12.77% |
| 2020-12-31 | $-6.38M | $35.84M | $8.65M | $5.77M | (m) | -17.81% |
| 2020-09-30 | $-2.36M | $47.65M | $10.11M | $6.06M | (m) | -4.96% |
| 2020-06-30 | $-4.35M | $45.33M | $9.55M | $6.51M | (m) | -9.60% |
| 2020-03-31 | $-4.15M | $45.15M | $8.73M | $6.80M | (m) | -9.18% |
| 2019-12-31 | $-3.62M | $45.55M | $8.75M | $6.48M | (m) | -7.95% |
| 2019-09-30 | $-4.89M | $46.81M | $8.80M | $6.69M | (m) | -10.44% |
| 2019-06-30 | $-4.85M | $44.93M | $8.34M | $6.72M | (m) | -10.79% |
| 2019-03-31 | $-5.12M | $43.52M | $7.85M | $6.71M | (m) | -11.76% |
| 2018-12-31 | $-7.39M | $40.20M | $7.38M | $7.32M | (m) | -18.38% |
| 2018-09-30 | $-6.03M | (m) | (m) | $5.61M | (m) | (m) |
| 2018-06-30 | $-5.06M | (m) | (m) | $5.25M | (m) | (m) |
| 2018-03-31 | $-5.88M | (m) | (m) | $4.88M | (m) | (m) |
| 2017-12-31 | $-4.08M | (m) | (m) | $3.90M | (m) | (m) |
| 2017-09-30 | $-4.14M | (m) | (m) | $4.08M | (m) | (m) |
| 2017-06-30 | $-3.17M | (m) | (m) | $3.78M | (m) | (m) |
| 2017-03-31 | $-1.59M | (m) | (m) | $3.38M | (m) | (m) |
| 2016-12-31 | $-1.43M | (m) | (m) | $3.19M | (m) | (m) |
| 2016-09-30 | $-313.08K | (m) | (m) | $2.43M | (m) | (m) |
| 2016-06-30 | $-172.33K | (m) | (m) | $2.55M | (m) | (m) |
| 2016-03-31 | $606.91K | (m) | (m) | $2.70M | (m) | (m) |
| 2015-12-31 | $1.11M | (m) | (m) | $3.85M | (m) | (m) |
| 2015-09-30 | $1.90M | (m) | (m) | $4.21M | (m) | (m) |
| 2015-06-30 | $2.61M | (m) | (m) | $4.39M | (m) | (m) |
| 2015-03-31 | $3.15M | (m) | (m) | $4.42M | (m) | (m) |
| 2014-12-31 | $3.56M | (m) | (m) | $3.39M | (m) | (m) |
| 2014-09-30 | $140.62K | $35.73M | (m) | $3.96M | (m) | 0.39% |
| 2014-06-30 | $-2.36M | $32.53M | (m) | $4.47M | (m) | -7.26% |
| 2014-03-31 | $-4.72M | $29.86M | (m) | $4.99M | (m) | -15.80% |
| 2013-12-31 | $-3.80M | $32.03M | (m) | $5.62M | (m) | -11.87% |
| 2013-09-30 | $1.92M | $37.56M | (m) | $4.72M | (m) | 5.12% |
| 2013-06-30 | $6.42M | $43.57M | (m) | $4.97M | (m) | 14.73% |
| 2013-03-31 | $9.50M | $48.85M | (m) | $5.14M | (m) | 19.44% |
| 2012-12-31 | $8.82M | $48.85M | (m) | $5.10M | (m) | 18.05% |
| 2012-09-30 | $7.28M | $48.19M | (m) | $6.41M | (m) | 15.10% |
| 2012-06-30 | $7.40M | $48.71M | (m) | $5.95M | (m) | 15.18% |
| 2012-03-31 | $9.09M | $50.73M | (m) | $5.42M | (m) | 17.91% |
| 2011-12-31 | $9.85M | $51.14M | (m) | $5.03M | (m) | 19.26% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $6.50M | $45.88M | (m) | $4.33M | (m) | 14.17% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $5.78M | $43.54M | (m) | $4.99M | (m) | 13.27% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |